Status:
UNKNOWN
Robotic Versus Laparoscopic Surgery for Patients With Pancreatic Cystic Neoplasms
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Pancreatic Neoplasm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Pancreatic cystic neoplasm (PCN) is a type of neoplastic lesion formed by the proliferation of pancreatic duct or acinar epithelial cells and retention of pancreatic secretions. The tumor can be locat...
Detailed Description
Background: Pancreatic cystic neoplasm (PCN) is a type of neoplastic lesion formed by the proliferation of pancreatic duct or acinar epithelial cells and retention of pancreatic secretions. Its hetero...
Eligibility Criteria
Inclusion
- 18 years old or older;
- Diagnosed as PCN;
- Patients with head or neck PCNs are eligible for minimal invasive PD, or patients with distal PCNs are eligible for minimal invasive DP.
Exclusion
- Not a PCN base on the sample's pathology;
- Procedure change from MIDP/MIPD to others during the operation;
- ASA more than 4;
- Patients or families deny certain treatment.
Key Trial Info
Start Date :
April 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05259384
Start Date
April 17 2021
End Date
October 31 2024
Last Update
February 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Beijing, China, 100730